Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Merck
Teva
McKesson
Deloitte
Farmers Insurance
Novartis
Accenture
Dow

Generated: February 25, 2018

DrugPatentWatch Database Preview

Glyburide - Generic Drug Details

« Back to Dashboard

What are the generic sources for glyburide and what is the scope of glyburide patent protection?

Glyburide
is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Actavis Elizabeth, Aurobindo Pharma, Epic Pharma Llc, Heritage Pharms Inc, Impax Labs Inc, Pharmadax Inc, Teva, Zydus Pharms Usa Inc, Dava Pharms Inc, Hikma, Mylan, Yaopharma Co Ltd, Pharmacia And Upjohn, and Bristol Myers Squibb, and is included in twenty-five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for glyburide. Forty-five suppliers are listed for this compound.
Pharmacology for glyburide
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for glyburide

US Patents and Regulatory Information for glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076345-003 Feb 18, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Epic Pharma Llc GLYBURIDE glyburide TABLET;ORAL 076257-002 Jun 27, 2002 AB1 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma GLYBURIDE glyburide TABLET;ORAL 077537-002 Oct 18, 2007 AB1 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva GLYBURIDE glyburide TABLET;ORAL 074388-003 Aug 29, 1995 AB1 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc GLYBURIDE glyburide TABLET;ORAL 206079-003 Sep 30, 2015 AB2 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma GLYBURIDE (MICRONIZED) glyburide TABLET;ORAL 075890-002 Jul 31, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva GLYBURIDE glyburide TABLET;ORAL 074388-002 Aug 29, 1995 AB1 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc GLYBURIDE glyburide TABLET;ORAL 206749-003 May 10, 2016 AB1 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 206748-001 Feb 29, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 076345-002 Feb 18, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DIABETA glyburide TABLET;ORAL 017532-003 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DIABETA glyburide TABLET;ORAL 017532-001 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-002 May 1, 1984 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DIABETA glyburide TABLET;ORAL 017532-001 May 1, 1984 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DIABETA glyburide TABLET;ORAL 017532-002 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Fuji
Cipla
Cantor Fitzgerald
AstraZeneca
QuintilesIMS
Harvard Business School
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot